In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime

APMIS

Volumn 110, Issue 7-8, 2002, Pages 559-564

  Skov, Robert ^a   Frimodt Møller, Niels ^a   Espersen, Frank ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Amoxycillin; Clavulanic acid; Staphylococcus aureus; Susceptibility testing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFUROXIME; CLAVULANIC ACID; DICLOXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG MIXTURE; DRUG STABILITY; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME STABILITY; ENZYME SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BETA-LACTAMASES; CEFUROXIME; DICLOXACILLIN; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC;

EID: 0036695465     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.11007807.x     Document Type: Article

References (21)

1. Espersen F, Rosdahl VT, Frimodt-Møller N, Skinhoj P. Epidemiology of Staphylococcus aureus bacteremia in Denmark. J Chemother 1994;6:219-25.
2. Turnidge J, Grayson ML. Optimum treatment of staphylococcal infections. Drugs 1993;45:353-66.
3. Craig WA. Penicillins. In: Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious Diseases. 2nd ed. Philadelphia: W. B. Saunders; 1998,173-85.
4. McDougal LK, Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986;23:832-9.
5. Moreillon P. Amoxycillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections. J Antimicrob Chemother 1995;35:435-41.
6. Todd PA, Benfield P. Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1990;39:264-307.
7. Bonfiglio G, Livermore DM. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations. J Antimicrob Chemother 1993;32:431-44.
8. Skov RL, Williams TJ, Pallesen L, Rosdahl VT, Espersen F. beta-Lactamase production and genetic location in Staphylococcus aureus: introduction of a beta-lactamase plasmid in strains of phage group II. J Hosp Infect 1995;30:111-24.
9. Blair JE, Williams REO. Phage typing of staphylococci. Bull WHO 1961;24:771-84.
10. Parker MT. The significance of phage typing in Staphylococcus aureus infections. In: Eastmon CSF, Adlam C, editors. Staphylococci and Staphylococcal infections. London: Academic Press; 1983,33-62.
11. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-91.
12. Ball P, Geddes A, Rolinson G. Amoxycillin clavulanate: an assessment after 15 years of clinical application. J Chemother 1997;9:167-98.
13. Cantoni L, Wenger A, Glauser MP, Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis 1989;159:989-93.
14. Catherall EJ, Irwin R, Mizen LW. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat. J Antimicrob Chemother 1991;27:117-26.
15. Gisby J, Beale AS, Bryant JE, Toseland CD. Staphylococcal osteomyelitis-a comparison of coamoxiclav with clindamycin and flucloxacillin in an experimental rat model. J Antimicrob Chemother 1994;34:755-64.
16. Moreillon P. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections. J Chemother 1994;6 (Suppl 2):51-7.
17. National Committee for Clinical Laboratory Standards. Performance standards for anti-microbial disk susceptibility tests; Approved Standard - M2-A7. 7th ed. 2000. Wayne, PA, National Committee for Clinical Laboratory Standards.
18. Thomson CJ, Miles RS, Amyes SG. Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio. Antimicrob Agents Chemother 1995;39:2591-2.
19. Kernodle DS, Voladri RK, Kaiser AB. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection. J Infect Dis 1998;177:701-6.
20. Frimodt-Moller N, Rosdahl VT, Gahrn-Hansen B. In vitro activity of dicloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. APMIS 1989;97:207-11.
21. Laverdiere M, Welter D, Sabath LD. Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother 1978;13:669-75.